Request appointment
10903 New Hampshire AveRm 2181Silver Spring, MD 20993
Overview of Dr. Vellanki
I am a board certified oncologist and I work at the FDA reviewing clinical trials for thoracic and head and neck cancers. I also care for patients with head and neck cancer in clinic at the University of Maryland, School of Medicine. My interests include cancer genetics, precision medicine, and drug development.
Education & Training
Johns Hopkins UniversityFellowship, Medical Oncology, 2017 - 2019
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2013 - 2016
University of Maryland School of MedicineClass of 2013
Certifications & Licensure
MD State Medical License 2016 - 2026
NC State Medical License 2013 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Landmark ctDNA molecular response represents an early predictor of immunotherapy outcomes in lung cancer: A clinical validity study.Noushin Niknafs, Lavanya Sivapalan, Archana Balan, Jaime Wehr, Gavin Pereira
Clinical Cancer Research. 2026-07-23 - 7 citationsThe Retrofit: Lessons From Sotorasib's Dosing Conundrum.Harpreet Singh, Paz J Vellanki, Richard Pazdur
Journal of Clinical Oncology. 2025-01-20 - 27 citationsPlasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group.Alexander W Wyatt, Saskia Litiere, Francois-Clément Bidard, Luc Cabel, Lars Dyrskjøt
Clinical Cancer Research. 2024-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: